These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18334731)

  • 1. The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop.
    Block TM; Marrero J; Gish RG; Sherman M; London WT; Srivastava S; Wagner PD
    Cancer Biomark; 2008; 4(1):19-33. PubMed ID: 18334731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for the early diagnosis of hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma abnormal prothrombin (PIVKA-II): a new and reliable marker for the detection of hepatocellular carcinoma.
    Takikawa Y; Suzuki K; Yamazaki K; Goto T; Madarame T; Miura Y; Yoshida T; Kashiwabara T; Sato S
    J Gastroenterol Hepatol; 1992; 7(1):1-6. PubMed ID: 1371940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma.
    Van Hees S; Michielsen P; Vanwolleghem T
    World J Gastroenterol; 2016 Oct; 22(37):8271-8282. PubMed ID: 27729734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New frontiers in biomarkers for hepatocellular carcinoma.
    Giannelli G; Antonaci S
    Dig Liver Dis; 2006 Nov; 38(11):854-9. PubMed ID: 16782417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma nuclear factor kappa B and serum peroxiredoxin 3 in early diagnosis of hepatocellular carcinoma.
    Ismail S; Mayah W; Battia HE; Gaballah H; Jiman-Fatani A; Hamouda H; Afifi MA; Elmashad N; Saadany SE
    Asian Pac J Cancer Prev; 2015; 16(4):1657-63. PubMed ID: 25743848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer markers for hepatocellular carcinoma.
    Marrero JA; Lok AS
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S113-9. PubMed ID: 15508074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma.
    Vasuri F; Malvi D; Bonora S; Fittipaldi S; Renzulli M; Tovoli F; Golfieri R; Bolondi L; D'Errico A
    Histopathology; 2018 Feb; 72(3):414-422. PubMed ID: 28881044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for hepatocellular carcinoma.
    Nguyen MH; Keeffe EB
    J Clin Gastroenterol; 2002; 35(5 Suppl 2):S86-91. PubMed ID: 12394211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Glypican3 be diagnostic for early hepatocellular carcinoma among Egyptian patients?
    Abdelgawad IA; Mossallam GI; Radwan NH; Elzawahry HM; Elhifnawy NM
    Asian Pac J Cancer Prev; 2013; 14(12):7345-9. PubMed ID: 24460300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.
    Tremosini S; Forner A; Boix L; Vilana R; Bianchi L; Reig M; Rimola J; Rodríguez-Lope C; Ayuso C; Solé M; Bruix J
    Gut; 2012 Oct; 61(10):1481-7. PubMed ID: 22287594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
    Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma].
    Luo X; Wei YQ; Hai L; Hu YC; Zhao ZJ; Ma WL; Ma LN; Liu XY; Ding XC
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):505-510. PubMed ID: 31357775
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.
    Wang N; Cao Y; Song W; He K; Li T; Wang J; Xu B; Si HY; Hu CJ; Li AL
    J Gastroenterol Hepatol; 2014; 29(7):1544-50. PubMed ID: 24612022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to improve the histopathological diagnosis of hepatocellular carcinoma in daily practice?].
    Honsová E; Lodererová A
    Cesk Patol; 2011 Apr; 47(2):40-3. PubMed ID: 21604432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and staging of hepatocellular carcinoma.
    Talwalkar JA; Gores GJ
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S126-32. PubMed ID: 15508076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and immunologic diagnosis of cancer. Hepatocellular cancer.
    Hirai H
    Tumour Biol; 1987; 8(2-3):86-93. PubMed ID: 2452470
    [No Abstract]   [Full Text] [Related]  

  • 20. Early HCC: diagnosis and molecular markers.
    Sakamoto M
    J Gastroenterol; 2009; 44 Suppl 19():108-11. PubMed ID: 19148803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.